TechFlow news, September 20: Faraday Future (NASDAQ: FFAI) announced today that it will strategically invest $41 million in Qualigen Therapeutics (NASDAQ: QLGN) through a PIPE transaction. The latter will be renamed CXC10 and transition into a crypto and Web3 business platform. The investor lineup is strong, including not only Faraday Future and Jia Yueting personally, but also SIGN Foundation, a blockchain technology company backed by YZI Labs, Sequoia Capital (US, India, China), IDG, and Circle.
Navigating Web3 tides with focused insights
Contribute An Article
Media Requests
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / support@techflowpost.com ICP License: 琼ICP备2022009338号




